Call for Poster Abstracts

Document Sample
Call for Poster Abstracts Powered By Docstoc
					                                                                                 15th Annual Symposium
                                                                            Call for Poster Abstracts

PCNA is now accepting poster abstracts for the 15th Annual Symposium                             Important Dates:
Cardiovascular Risk Reduction: Leading the Way in Prevention                               Feb 15 – Submission Deadline

April 16-18, 2009 – Hyatt Regency, Dallas, TX                                            Feb 27 – Notification of Acceptance

INVITATION: We invite healthcare professionals involved in original data-based research or clinical patient management
programs related to cardiovascular risk reduction & disease management to submit an abstract. Submission of a poster
abstract constitutes a commitment by the author to present the poster if accepted. Poster Presentations will take place on
Thursday, April 16th during a special reception at the Hyatt Regency in Dallas, TX. All posters will be randomly numbered
and displayed together in the foyer outside of the exhibit hall.
PURPOSE: The purpose of the poster session is to present original research findings and share new and innovative ideas
for successful approaches to cardiovascular risk reduction and disease management. PCNA is proud to provide a forum
for members and colleagues to share their ideas and best practices.

AWARDS: A $250 award will be given to the most innovative and scientifically significant poster in each of these two
categories: 1. Data-Based Research
            2. Clinical Patient Management

During the Symposium, a first, second, or third place ribbon will be placed on winning posters. All presenters and winners
will be recognized during PCNA General Sessions on Friday, April 17, 2009. All accepted posters will be published in the
conference syllabus. First place poster abstracts will be published in the Journal of Cardiovascular Nursing.
SELECTION PROCESS: Each presenting author must submit two forms of their abstract: the first must list all authors and
the second must be “blinded,” excluding author information. The PCNA Abstract Review Committee will make selections
using a blind review process. In order to be accepted for review, abstracts must adhere to the guidelines set forth in this
Call for Abstracts and must be received via the PCNA online submission form no later than February 15, 2009. Authors
will be notified by February 27, 2009 of acceptance.

                                      Grading Criteria for Each Category
       Data-Based Research                                           Clinical Patient Management
                                                                     Including quality improvement projects and
                                                                     patient education/counseling programs

  1.    The investigation should be based on original           1.     The project/program should be based on original
        concepts and provide important new data.                       concepts and provide important new information or
                                                                       techniques.
  2.    The topic should be relevant to the theme of the
        meeting and/or mission of PCNA.                         2.     The topic should be relevant to the theme of the
                                                                       meeting and/or mission of PCNA.
  3.    The study design and methodology of the research
        project should be appropriate.                          3.     The description of the project/program should be
                                                                       clearly presented. If a QI project, the design and
  4.    The abstract should include complete data
                                                                       methodology should be appropriate.
        (mentioning that the results will be presented at the
        meeting is unsatisfactory).                             4.     The abstract should include complete information or
                                                                       outcomes (mentioning that the results will be
  5.    The findings should be factual, unique, useful, and
                                                                       presented at the meeting is unsatisfactory)
        appropriate to the PCNA audience.
                                                                5.     The findings should be factual, unique, useful, and
  6.    The conclusions should be valid.
                                                                       appropriate to the PCNA audience.
  7.    The abstract should be well written (i.e., clear and
                                                                6.     The conclusions should be valid.
        easy to understand).
                                                                7.     The abstract should be well written (i.e., clear and
                                                                       easy to understand).
                    PCNA 2009 Poster Abstract Submission Guidelines:
Your abstract should focus on a topic that        The following components are required in each abstract:
represents one of these two categories:
                                                       Background summary
  1. Data-Based Research
                                                       Statement of specific objectives
  2. Clinical Patient Management
                                                       Description of design & methods, including measurements
                                                       Summary of the results obtained
                                                       Statement of the conclusions


     Preferred style: Examples of winning abstracts are included on the following page. Please include section
      headers such as Background, Objective, Methods, Results, and Conclusion.

     Submission of a poster abstract constitutes a commitment by the author to present the poster if accepted

     Industry representatives (i.e. from device/pharmaceutical/food companies) cannot be first author on any
      submitted abstracts to avoid a potential conflict of interest

     Arial font, 10 point minimum is required.

     The abstract itself may not exceed a word count of 300. The 300 word limit does not include title or
      author(s) information

     Do not indent the title and be certain that it is completely CAPITALIZED, but do not use capitals or
      underline for emphasis within the body of your abstract (this will be lost in the electronic transfer)

     For each author, please list full name followed by degrees/credentials, employer, and city/state

     Be sure that street address, zip code, degrees, and grant support are NOT listed in abstracts

     Deadline for submission is 11:59 pm on February 15, 2009. Submissions received after this date will not
      be accepted for review

     If you do not receive an e-mail confirmation within five business days, it is your responsibility to contact the
      PCNA National Office to make sure we have received your submission

     Any author may not be first author on more than two submissions

     Any investigator may not present more than two posters

     When using abbreviations, spell out in full the first mention, followed by the abbreviation in parentheses

     Do not squeeze letters or lines

     Left-hand border must be perfectly straight

     Check accuracy of spelling, grammar, and punctuation: Your poster abstract will appear in print exactly as
      you submit it; thus any errors, misspellings, incorrect hyphenations, or deviations from good grammatical
      usage will appear in the published abstract



                    Submit your abstract online at www.pcna.net
                                                   Questions?
                                         Please contact Kristie Kasbohm
                                             Tel: 608-250-2440 x 1
                                          E-mail: kkasbohm@pcna.net
   2008 Winning Abstracts – Presented at the PCNA 14th Annual Symposium in Orlando


1st Place Winner: Data-Based Research
DIETARY ENERGY DENSITY: A POTENTIAL MEDIATOR OF DISEASE RISK IN OVERWEIGHT ADULTS
Daurice A. Grossniklaus, RN, MS, ME, Margaret F. Pedersen, RD, LD, Sandra B. Dunbar, RN, DSN, FAAN
Emory University, Atlanta, GA
                              Background: Abdominal obesity is associated with insulin resistance and cardiometabolic
                              disease. In 2003-2004, more than 50% of adults had abdominal obesity. A conceptual model
                              accounting for environmental demands predisposing individuals to psychological distress is
                              proposed. Depending on coping behaviors and resources, psychological distress may alter
                              biobehavioral responses contributing to abdominal obesity. Increased dietary energy density
                              (DED) represents a risk factor for abdominal fat deposition due to excess intake of energy,
                              total and saturated fats. DED is a potential biobehavioral mediator between psychological
                              distress and abdominal obesity.
Objectives: This study examines associations among psychological factors, biobehavioral response, and disease risk in
overweight adults and compares DED values to a national sample.
Methods: Adults 18-65 years without coronary artery disease were recruited for this correlation study. Inclusion: Body
mass index (BMI) > 25.0 kg/m2 and sedentary lifestyle. Exclusion: Pregnant, breastfeeding, diabetic, or engaged in weight
loss activities. Variables and measures: Demographic data, depressive symptoms (Beck Depression Inventory II [BDI-II]),
perceived stress (Perceived Stress Scale [PSS]), dietary energy density ([DED] weighed three-day food record to
calculate kilocalories/gram of food and beverages), and abdominal obesity (waist circumference [WC] using NHANES
procedures). Data analysis: Descriptive statistics, Pearson’s correlation to test relationships between PSS, BDI-II and WC
and one sample t-tests to compare study DED with national sample.
Summary: The sample (N=32) was 78% women, 58% African American, 20-57 years, mean BMI=32.39 kg/m2 and mean
WC=101.23 cm. Moderate correlations between BDI-II and PSS (r=0.601, p<0.0001), and between PSS and WC
(r=0.360, p=0.043) were found. Food and beverage DED was significantly less than national sample (t=-2.805 p=0.009).
Conclusions: As perceived stress increased, depressive symptoms and waist circumference increased. Food and
beverage DED was lower than national sample due to inclusion of water in DED calculations. Methodological challenges
are subject underreporting and inclusion/exclusion of beverages in calculating DED.


1st Place Winner: Clinical Patient Management
TAPPING INTO THE UNDER-DIAGNOSED CONDITION OF PERIPHERAL ARTERIAL DISEASE THROUGH
COMPREHENSIVE VASCULAR ASSESSMENTS
Kelly A. Galler, MSN, GNP, Bellin Health, Green Bay, WI
                              Background: Approximately eight to ten million Americans have Peripheral Arterial Disease
                              (PAD). Three out of four Americans know little or nothing about PAD and evaluations for
                              vascular disease are not routinely done in the primary care setting. The ankle brachial index
                              (ABI) is an easy and non-invasive test that can diagnosis PAD.
                              Objective: The goals of this program are to: 1) Increase awareness in the primary care
                              setting and community, 2) Promote prevention through risk factor modification and
                              counseling, 3) Assist with early identification of vascular disease in the community.
Methods: A resource booklet called Guidelines for Vascular Disease was developed and given to primary care physicians
in conjunction with a lecture series on vascular disease. Through avenues such as TV, newspaper articles, direct mailing,
and educational pamphlets, the community has been made aware of the symptoms and risk factors of vascular disease
and have been encouraged to take advantage of a free comprehensive vascular assessment. Key components of the
assessment include palpation and auscultation of pulses, abdominal aorta palpation, lower extremity evaluation for signs
of decreased circulation and an ABI.
Results: Primary care providers are referring patients into the program and individuals are scheduling themselves for
vascular assessments. 232 patients have had a vascular assessment between August 2007 and January 2008. Each
person has received risk factor modification counseling specific to their individual needs. 12% of these patients, age range
28 to 92, have been diagnosed with PAD through resting ABI assessment.
Conclusion: Education materials have proven to be an effective tool to increase awareness and promote vascular
assessments in the community. An overwhelming response of appreciation for risk factor counseling and early
identification of PAD has been expressed from the community.